Krystal Biotech Inc

NASDAQ:KRYS   3:59:56 PM EDT
78.68
+0.68 (+0.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Krystal Biotech Inc Stock, NASDAQ:KRYS

2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203
United States of America
Phone: +1.412.586.5830
Number of Employees: 75

Description

Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The company was founded by Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.